Shammas NW, Boyes CW, Palli SR, Rizzo JA, Martinsen BJ, Kotlarz H, Mustapha JA. Hospital cost impact of orbital atherectomy with angioplasty for critical limb ischemia treatment: a modeling approach.
J Comp Eff Res 2017;
7:305-317. [PMID:
29072090 DOI:
10.2217/cer-2017-0070]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
AIM
The incremental cost of peripheral orbital atherectomy system (OAS) plus balloon angioplasty (BA) versus BA-only for critical limb ischemia was estimated.
MATERIALS & METHODS
A deterministic simulation model used clinical and healthcare utilization data from the CALCIUM 360° trial and current cost data. Incremental cost of OAS + BA versus BA-only included differential utilization during the procedure and adverse-event costs at 3, 6 and 12-months.
RESULTS
For every 100 procedures, incremental annual costs to the hospital were US$350,930 lower with OAS + BA compared with BA-only. Despite higher upfront costs, savings were realized due to reduced need for revascularization, amputation and end-of-life care over 6-12-month postoperative period.
CONCLUSION
Atherectomy with OAS prior to BA was associated with cost savings to the hospital.
Collapse